LabCorp(R) Completes Acquisition of Dynacare Inc.

BURLINGTON, N.C., Jul 25, 2002 /PRNewswire-FirstCall via COMTEX/ -- Estimated $45 Million in Annual Cost Savings Expected by Year-End 2004 Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced it has completed its previously announced acquisition of Dynacare Inc., a

Laboratory Corporation of America(R) Announces Second Quarter Results

BURLINGTON, N.C., Jul 24, 2002 /PRNewswire-FirstCall via COMTEX/ -- EBITDA Hits Record Level of 25.5 Percent of Net Sales; Dynacare Shareholders Approve Acquisition by LabCorp; Closing Expected July 25th Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results

Laboratory Corporation of America(R) Schedules Second Quarter 2002 Results Conference Call

BURLINGTON, N.C., Jul 19, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) expects to release second quarter financial results at approximately 5:00 p.m. Eastern Time on July 24, 2002. A conference call has been scheduled for Thursday,

Laboratory Corporation of America(R) Signs Group Purchasing Agreement With Premier

BURLINGTON, N.C., Jul 15, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that it has signed a national contract with San Diego-based Premier, Inc., one of the country's largest group purchasing organizations.

EXACT Sciences and LabCorp(R) to Offer PreGen-Plus(TM), Changing the Health Care Landscape With Non-Invasive, Genomics-Based Colorectal Cancer Technology

MAYNARD, Mass. and BURLINGTON, N.C., Jun 27, 2002 /PRNewswire-FirstCall via COMTEX/ -- Exclusive Licensing Agreement to Make PreGen-Plus Available to a Potential Market of 80 Million Americans; Will Mark the First DNA-based Screening Method For Cancer in an Average-Risk Population EXACT Sciences

LabCorp(R) Announces Expiration of Antitrust Waiting Period In Offer for Dynacare Inc.

BURLINGTON, N.C., Jun 20, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act with respect to its offer to purchase all outstanding shares of

LabCorp(R) Scheduled to Present at the Goldman, Sachs & Company Global Health Care Conference

BURLINGTON, N.C., Jun 11, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of public affairs, is scheduled to speak at the Goldman, Sachs & Company Global Health Care

LabCorp to Co-Sponsor Educational Web Cast on Bladder Cancer Recurrence

BURLINGTON, N.C., Jun 6, 2002 /PRNewswire-FirstCall via COMTEX/ -- LabCorp First to Offer Abbott Vysis(R) UroVysion Test for Early Detection of Recurring Bladder Cancer Laboratory Corporation of America Holdings (NYSE: LH) (LabCorp(R)) today announced its co-sponsorship of a landmark Web cast with

LabCorp Exclusively Offers Myriad Genetics' Predictive Medicine Products

BURLINGTON, N.C., Jun 5, 2002 /PRNewswire-FirstCall via COMTEX/ -- Physicians Can Offer Predisposition Testing for Various Cancers And Hypertension Through LabCorp's Patient Service Centers Laboratory Corporation of America Holdings (NYSE: LH) (LabCorp(R)) today announced the implementation of its

Laboratory Corporation of America(R) Announces Definitive Agreement to Acquire Dynacare Inc.

BURLINGTON, N.C. and DALLAS, May 9, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), a national clinical laboratory with 2001 revenues of $2.2 billion, and Dynacare Inc. (Nasdaq: DNCR; Toronto: DNA), a leading independent provider of